Interferon- α for TP53 Myeloid Malignancy Post Allo-HSCT

Conditions: Myeloid Leukemia; Myelodysplastic Syndromes Interventions: Drug: IFN- Α Sponsors: Peking University People ' s Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials